Return to homepagePandemic Pact

ASPR-21-00560 - BASE PERIOD FUNDS FOR LUMINEX CORPORATION - EXPAND THE USE OF THE ARIES SARS-COV-2 ASSAY

  • Funded by Biomedical Advanced Research and Development Authority (BARDA)
  • Total publications:0 publications

Grant number: 75A50121P00025

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    2021
    2022

  • Known Financial Commitments (USD)

    $11,336,921

  • Funder

    Biomedical Advanced Research and Development Authority (BARDA)

  • Research Location

    United States of America

  • Lead Research Institution

    LUMINEX CORP

  • Research Priority Alignment

    N/A

  • Research Category

    13

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

ASPR-21-00560 - BASE PERIOD FUNDS FOR LUMINEX CORPORATION - EXPAND THE USE OF THE ARIES SARS-COV-2 ASSAY